Literature DB >> 29524736

Harnessing the language of overdose prevention to advance evidence-based responses to the opioid crisis.

Alexandra B Collins1, Ricky N Bluthenthal2, Jade Boyd3, Ryan McNeil4.   

Abstract

Language has significant implications for how we view and respond to public health issues. Conventional moralistic messaging around drug use stigmatizes people who use drugs and inhibits the implementation of evidence-based harm reduction interventions that do not condemn drug use. However, within the context of the unprecedented North American opioid overdose crisis, we argue that shifting conventional moral messaging around overdose prevention and response strategies is key to supporting the rapid roll-out of evidence-based harm reduction interventions. Reframing overdose prevention to highlight the imperative to address the ongoing public health emergency is an important first step in implementing urgently needed response strategies.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug policy; Harm reduction; Language; Overdose

Mesh:

Substances:

Year:  2018        PMID: 29524736      PMCID: PMC6415683          DOI: 10.1016/j.drugpo.2018.02.013

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  9 in total

1.  Effectiveness and framing of pharmaceutical opioid abuse-deterrent formulations.

Authors:  Amy Peacock; Briony Larance; Raimondo Bruno; Sallie-Anne Pearson; Nicholas A Buckley; Michael Farrell; Louisa Degenhardt
Journal:  Addiction       Date:  2019-03       Impact factor: 6.526

2.  Overdose Prevention Site Acceptability among Residents and Businesses Surrounding a Proposed Site in Philadelphia, USA.

Authors:  Alexis M Roth; Alex H Kral; Allison Mitchell; Rohit Mukherjee; Peter Davidson; Stephen E Lankenau
Journal:  J Urban Health       Date:  2019-06       Impact factor: 3.671

3.  "Bed Bugs and Beyond": An ethnographic analysis of North America's first women-only supervised drug consumption site.

Authors:  Jade Boyd; Jennifer Lavalley; Sandra Czechaczek; Samara Mayer; Thomas Kerr; Lisa Maher; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2020-04-02

4.  Policing space in the overdose crisis: A rapid ethnographic study of the impact of law enforcement practices on the effectiveness of overdose prevention sites.

Authors:  Alexandra B Collins; Jade Boyd; Samara Mayer; Al Fowler; Mary Clare Kennedy; Ricky N Bluthenthal; Thomas Kerr; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2019-09-18

5.  Navigating post-eviction drug use amidst a changing drug supply: A spatially-oriented qualitative study of overlapping housing and overdose crises in Vancouver, Canada.

Authors:  Ryan McNeil; Taylor Fleming; Alexandra B Collins; Sandra Czechaczek; Samara Mayer; Jade Boyd
Journal:  Drug Alcohol Depend       Date:  2021-03-18       Impact factor: 4.492

6.  Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment.

Authors:  Annabelle M Belcher; Thomas O Cole; Aaron D Greenblatt; Stephen W Hoag; David H Epstein; Michael Wagner; Amy S Billing; Ebonie Massey; Kristen R Hamilton; Zofia K Kozak; Christopher J Welsh; Eric Weintraub; Emerson M Wickwire; Eric D Wish; Ted J Kaptchuk; Luana Colloca
Journal:  BMJ Open       Date:  2019-06-21       Impact factor: 2.692

Review 7.  Lessons learned from the opioid crisis across the pillars of the Canadian drugs and substances strategy.

Authors:  Sheena Taha; Bridget Maloney-Hall; Jane Buxton
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-08-19

8.  Negotiating sex work and client interactions in the context of a fentanyl-related overdose epidemic.

Authors:  Jennifer Lavalley; Alex B Collins; Samara Mayer; Laurel Gaudette; Andrea Krüsi; Ryan McNeil; Jade Boyd
Journal:  Cult Health Sex       Date:  2020-09-08

9.  High willingness to use overdose prevention sites among female sex workers in Baltimore, Maryland.

Authors:  Saba Rouhani; Rebecca Hamilton White; Ju Nyeong Park; Susan G Sherman
Journal:  Drug Alcohol Depend       Date:  2020-05-11       Impact factor: 4.852

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.